In the DEN + CCI4 HCC model, the DEGs enrichment analysis of CD8+ T cell from LR-DPVB-treated tumors also revealed a significant association with T cell differentiation and activation, effector molecular response, as well as inflammatory and immune responses (Supplementary Fig. 5a). This evidence concerns the gene CD8A and hepatocellular carcinoma.